Russell Investments Group’s Enliven Therapeutics ELVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $593K | Sell |
29,547
-75,995
| -72% | -$1.52M | ﹤0.01% | 2275 |
|
|
2025
Q1 | $2.08M | Buy |
105,542
+105,471
| +148,551% | +$2.08M | ﹤0.01% | 1674 |
|
|
2024
Q4 | $1.6K | Buy |
71
+59
| +492% | +$1.33K | ﹤0.01% | 3479 |
|
|
2024
Q3 | $306 | Sell |
12
-1,426
| -99% | -$36.4K | ﹤0.01% | 3611 |
|
|
2024
Q2 | $33.6K | Buy |
1,438
+1,426
| +11,883% | +$33.3K | ﹤0.01% | 2848 |
|
|
2024
Q1 | $211 | Hold |
12
| – | – | ﹤0.01% | 3275 |
|
|
2023
Q4 | $166 | Buy |
+12
| New | +$166 | ﹤0.01% | 3185 |
|
|
2021
Q3 | – | Sell |
-48,476
| Closed | -$1.53M | – | 3083 |
|
|
2021
Q2 | $1.53M | Buy |
+48,476
| New | +$1.53M | ﹤0.01% | 2079 |
|